Status report
Get it in writing
The official USPTO status record for COME SEE ME, I AM DR. SIMI!, serial 99370271, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
COME SEE ME, I AM DR. SIMI!Serial 99370271 · Principal Register
Pending · Published for Opposition
Owner: FARMACIAS DE SIMILARES, S.A. DE C.V.
Class 035 - Advertising & Business
Filed Sep 02, 2025
The record shows that “COME SEE ME, I AM DR. SIMI!” is a pending service mark owned by FARMACIAS DE SIMILARES, S.A. DE C.V., a Mexican corporation. The mark is on the Principal Register and covers retail and online services for over‑the‑counter medicines, dietary supplements, cosmetics, medical devices, and souvenirs. A similar name would raise the closest concern in the same categories of health‑related retail and e‑commerce services. The record does not give the owner control over every use of the wording; it applies only to the goods and services listed. The most recent event is the Notice of Allowance issued on April 21, 2026, after which the applicant must file a Statement of Use or an Extension Request within six months. No opposition, cancellation, or court action appears in the supplied history, so there is no visible enforcement signal. If you plan to use a similar name in the same health‑product retail space, this record suggests a meaningful risk of conflict.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.